Inventor · disambiguated record
Robert D. Thompson
Also filed as: THOMPSON ROBERT · THOMPSON ROBERT D · THOMPSON ROBERT DOUGLAS
38 granted patents·12 pending applications·748 citations·filing 1985–2025
98Inventor score
Files withPGX HEALTH LLC5PGXHEALTH LLC5ADENOSINE THERAPEUTICS LLC4LEWIS AND CLARK PHARMACEUTICALS INC4WANG GUOQUAN4
Top patents by PatentIndex Score
50 records- 0197US7579348B2Derivatives of 8-substituted xanthinesPGXHEALTH LLC·Filed 2006·Granted Aug 25, 2009·124 cites·47 claims
- 0294US7598379B2Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Oct 6, 2009·14 cites·10 claims
- 0394US5310731AN-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agentsWHITBY RESEARCH INC·Filed 1985·Granted May 10, 1994·124 cites·35 claims
- 0493US7576069B22-polycyclic propynyl adenosine analogs having A2A agonist activityUNIV VIRGINIA·Filed 2005·Granted Aug 18, 2009·36 cites·87 claims
- 0592US9067963B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2013·Granted Jun 30, 2015·30 cites·32 claims
- 0692US7589076B2Substituted aryl piperidinylalkynyladenosines as A2AR agonistsPGX HEALTH LLC·Filed 2007·Granted Sep 15, 2009·20 cites·43 claims
- 0790US7618962B2Pyrazolyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Nov 17, 2009·16 cites·59 claims
- 0889US7888329B2Substituted aryl piperidinylalkynyladenosines as A2AR agonistsPGXHEALTH LLC·Filed 2009·Granted Feb 15, 2011·12 cites·21 claims
- 0989US7732455B2Substituted 8-heteroaryl xanthinesPGX HEALTH LLC·Filed 2007·Granted Jun 8, 2010·12 cites·102 claims
- 1089US7601723B2Pyridyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Oct 13, 2009·17 cites·58 claims
- 1189US5278150A2-hydrazoadenosines and their utility for the treatmeat of vascular conditionsWHITBY RESEARCH INC·Filed 1992·Granted Jan 11, 1994·84 cites·28 claims
- 1289US5140015A2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agentsWHITBY RESEARCH INC·Filed 1990·Granted Aug 18, 1992·86 cites·16 claims
- 1387US7884100B2Substituted 8-[6-amino-3-pyridyl]xanthinesPGXHEALTH LLC·Filed 2007·Granted Feb 8, 2011·9 cites·48 claims
- 1487US7442687B22-polycyclic propynyl adenosine analogs having A2A agonist activityUNIV VIRGINIA·Filed 2005·Granted Oct 28, 2008·13 cites·67 claims
- 1587US7342006B2Substituted 8-heteroaryl xanthinesADENOSINE THERAPEUTICS LLC·Filed 2004·Granted Mar 11, 2008·27 cites·55 claims
- 1687US7217702B2Selective antagonists of A2A adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2005·Granted May 15, 2007·12 cites·86 claims
- 1786US7875595B22-polycyclic propynyl adenosine analogs having A2A agonist activityUNIV VIRGINIA·Filed 2009·Granted Jan 25, 2011·7 cites·26 claims
- 1885US7875608B2Substituted 8-[6-amino-3pyridyl]xanthinesTHOMPSON ROBERT D·Filed 2008·Granted Jan 25, 2011·9 cites·24 claims
- 1982US8058259B2Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT DOUGLAS·Filed 2008·Granted Nov 15, 2011·10 cites·19 claims
- 2078USRE36494E2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agentsDISCOVERY THERAPEUTICS INC·Filed 1993·Granted Jan 11, 2000·43 cites·11 claims
- 2176US12269828B2Cyclic amide-containing pyridyl xanthines as A2B antagonistsADOVATE LLC·Filed 2023·Granted Apr 8, 2025·0 cites·24 claims
- 2275US8293720B2Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT D·Filed 2008·Granted Oct 23, 2012·2 cites·30 claims
- 2375US8252767B2Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT·Filed 2008·Granted Aug 28, 2012·2 cites·25 claims
- 2475US8153628B2Pyrazolyl substituted xanthinesWANG GUOQUAN·Filed 2009·Granted Apr 10, 2012·2 cites·40 claims
- 2574US5043325AN-6 substituted adenosine derivatives as cardiac vasodilatorsWHITBY RESEARCH INC·Filed 1986·Granted Aug 27, 1991·21 cites·26 claims
- 2669US11814387B2Cyclic amide-containing pyridyl xanthines as A2B antagonistsPURNOVATE INC·Filed 2022·Granted Nov 14, 2023·0 cites·27 claims
- 2769US9822141B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2015·Granted Nov 21, 2017·1 cites·28 claims
- 2868US8420813B2Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesWANG GUOQUAN·Filed 2009·Granted Apr 16, 2013·0 cites·1 claims
- 2967US2025353850A1Cyclic amide-containing pyridyl xanthines as a2b antagonistsADOVATE LLC·Filed 2025·Application pending·0 cites
- 3066US8193200B2Antagonists of A2B adenosine receptors for treatment of inflammatory bowel diseaseSITARAMAN SHANTHI V·Filed 2007·Granted Jun 5, 2012·2 cites·2 claims
- 3166US7985754B2Selective antagonists of A2A adenosine receptorsTROVIS PHARMACEUTICALS LLC·Filed 2007·Granted Jul 26, 2011·1 cites·19 claims
- 3265US8222228B2Substituted aryl piperidinylalkynyladenosines as A2AR agonistsRIEGER JAYSON M·Filed 2010·Granted Jul 17, 2012·1 cites·8 claims
- 3364US8263762B2Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonistsBEAUGLEHOLE ANTHONY R·Filed 2010·Granted Sep 11, 2012·2 cites·33 claims
- 3460US8501941B2Methods for the synthesis of unsymmetrical cycloakyl substituted xanthinesWANG GUOQUAN·Filed 2012·Granted Aug 6, 2013·0 cites·9 claims
- 3560US2009181920A1Intrathecal treatment of neuropathic pain with a2ar agonistsPGXHEALTH LLC·Filed 2009·Application pending·0 cites
- 3659US2008176858A1Selective antagonists of a2a adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2008·Application pending·0 cites
- 3758US2007244134A1Selective antagonists of A2A adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2007·Application pending·0 cites
- 3857US2013109646A1Method for treating glaucoma or ocular hypertension with an adenosine derivativeSANTEN PHARMACEUTICAL CO LTD·Filed 2012·Application pending·0 cites
- 3956US7470697B2Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2007·Granted Dec 30, 2008·0 cites·396 claims
- 4056USRE37045EN-6 substituted-5′-(N-substituted carboxamide)adenosines as cardiac vasodilator and antihypertensive agentsDISCOVERY THERAPEUTICS INC·Filed 1999·Granted Feb 6, 2001·9 cites·35 claims
- 4156US2010093770A1Therapeutic agent for glaucoma containing adenosine derivative as active ingredientSHIMAZAKI ATSUSHI·Filed 2008·Application pending·0 cites
- 4253US8349848B2Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptorsDOGWOOF PHARMACEUTICALS INC·Filed 2008·Granted Jan 8, 2013·0 cites·18 claims
- 4353US2012309774A1Selective antagonists of a2a adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2012·Application pending·0 cites
- 4451US8258142B2Substituted 8-[6-amino-3-pyridyl]xanthinesWANG GUOQUAN·Filed 2010·Granted Sep 4, 2012·0 cites·5 claims
- 4551US2023144283A18-substituted diaryl xanthines as dual a2a-a2b antagonistsINSPYR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4651US2012035192A1Selective antagonists of a2a adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2011·Application pending·0 cites
- 4750US2019077824A1N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4848US2010273780A1Substituted 8-heteroaryl xanthinesPGXHEALTH LLC·Filed 2010·Application pending·0 cites
- 4942US2007049757A1Methods for the synthesis of substituted amino uracilsRIEGER JAYSON M·Filed 2006·Application pending·0 cites
- 5040US9593118B2Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2016·Granted Mar 14, 2017·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Robert D. Thompson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →